AGC Biologics, a global clinical and commercial manufacturer of therapeutic proteins, is adding a new building complex to house its global headquarters in Bothell, WA.

The new 150,000 sq.-ft. complex is adjacent to its existing biologics facility in Bothell, and will house the company's process development labs and corporate administrative offices, and will provide additional space for manufacturing capacity. The new facilities represent AGC’s continued expansion in the U.S., and will include a new R&D center dedicated to novel manufacturing technologies for faster development of therapeutic proteins.

"The expansion of our Bothell site is another substantial milestone for AGC Biologics and a commitment to our operations in Washington State. We continue to demonstrate our dedication to sustained growth in order to support our customers' increasing demand for both mammalian and microbial development and manufacturing services," said Gustavo Mahler, president and chief executive officer of AGC Biologics. "These new state-of-the-art facilities will enable us to meaningfully advance and further integrate the development, manufacturing, and commercial functions within our dynamic global headquarters, as well as provide additional footprint for further manufacturing expansion."